A detailed history of West Bancorporation Inc transactions in Abbott Laboratories stock. As of the latest transaction made, West Bancorporation Inc holds 5,773 shares of ABT stock, worth $657,313. This represents 0.46% of its overall portfolio holdings.

Number of Shares
5,773
Previous 7,493 22.95%
Holding current value
$657,313
Previous $851,000 29.61%
% of portfolio
0.46%
Previous 0.56%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$100.73 - $112.44 $173,255 - $193,396
-1,720 Reduced 22.95%
5,773 $599,000
Q4 2023

Jan 26, 2024

SELL
$90.19 - $110.4 $11,273 - $13,800
-125 Reduced 1.64%
7,493 $824,000
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $9,935 - $11,920
-104 Reduced 1.35%
7,618 $737,000
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $15,923 - $17,741
-158 Reduced 2.01%
7,722 $841,000
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $52,304 - $61,565
-540 Reduced 6.41%
7,880 $797,000
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $53,328 - $62,562
-561 Reduced 6.25%
8,420 $924,000
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $108,467 - $125,585
-1,121 Reduced 11.1%
8,981 $869,000
Q2 2022

Jul 15, 2022

SELL
$102.07 - $123.37 $47,360 - $57,243
-464 Reduced 4.39%
10,102 $1.1 Million
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $969,626 - $1.18 Million
8,504 Added 412.42%
10,566 $1.25 Million
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $154,348 - $188,990
-1,336 Reduced 39.32%
2,062 $290,000
Q3 2020

Oct 30, 2020

BUY
$91.64 - $111.29 $15,028 - $18,251
164 Added 5.07%
3,398 $370,000
Q2 2020

Jul 31, 2020

BUY
$76.57 - $98.0 $2,909 - $3,724
38 Added 1.19%
3,234 $296,000
Q1 2020

Apr 30, 2020

SELL
$62.82 - $91.86 $19,222 - $28,109
-306 Reduced 8.74%
3,196 $252,000
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $274,942 - $306,074
3,502 New
3,502 $304,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track West Bancorporation Inc Portfolio

Follow West Bancorporation Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Bancorporation Inc with notifications on news.